PUNE: The three vaccines against Covid-19 — Covovax, Corbevax and ZyCov-D — receiving the Drug Controller General of India’s nod last year for emergency use in the country are yet…
The Central Drugs Standard Control Organisation (CDSCO) has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking to 12 the number of preventives and…
Vaccine major Serum Institute of India (SII) on Tuesday said the approval for the COVID-19 vaccine ‘Covovax’ would strengthen immunization initiatives across India and various lower and middle income countries…
New Delhi: The Union Health Ministry on Tuesday granted approval to two Vaccines- Corbevax and Covovax and antiviral drug Molnupiravir following Emergency Use recommendations by the Central Drugs Standard Control…
An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to the Serum Institute of India’s COVID-19 vaccine Covovax and Biological E’s vaccine Corbevax with…
By Payal Banerjee, New Delhi An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India’s COVID-19 vaccine Covovax and Biological…
The grant of emergency approval to Covovax by the World Health Organization (WHO) has brightened the chances of the vaccine receiving approval from India’s drug regulator. Covovax is being manufactured…
Geneva: Covovax, produced by Serum Institute of India (SII) under the license from Novovax, became the ninth COVID-19 vaccine to receive Emergency Use Listing (EUL) from the World Health Organisation…
